These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2471931)

  • 1. The "hook effect": high concentrations of prostate-specific antigen giving artifactually low values on one-step immunoassay.
    Wolf BA; Garrett NC; Nahm MH
    N Engl J Med; 1989 Jun; 320(26):1755-6. PubMed ID: 2471931
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for carcinoma of the prostate with prostate specific antigen.
    Muschenheim F; Omarbasha B; Kardjian PM; Mondou EN
    Ann Clin Lab Sci; 1991; 21(6):371-80. PubMed ID: 1723583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.
    Cooner WH
    Invest Radiol; 1989 Mar; 24(3):257-9. PubMed ID: 2473962
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
    Mulders TM; Bruning PF; Bonfrer JM
    Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The detection of cancer of the prostate. Challenge for the 1990s?].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(6):385-7. PubMed ID: 2464966
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consensus conference. The detection of localized cancer of the prostate. Paris, 8-9 December 1989].
    Ann Urol (Paris); 1990; 24(1):5-8. PubMed ID: 1690964
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-specific antigen in adenocarcinoma of the prostate.
    N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value of prostate-specific antigen].
    Wirth M
    Urologe A; 1991 May; 30(3 Suppl):6. PubMed ID: 1720907
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate.
    Parra RO
    Mo Med; 1991 Jun; 88(6):349-52. PubMed ID: 1712422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study shows PSA better than DRE in screening for prostate cancer.
    Oncology (Williston Park); 1991 Nov; 5(11):36. PubMed ID: 1722420
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels.
    Alivizatos G; Pavlaki K; Giannopoulos A; Mitropoulos D; Tsega A; Deliveliotis C; Dimopoulos C
    Eur Urol; 1992; 21(2):141-5. PubMed ID: 1379922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.